-

New Study finds Volumetric Absorptive Micro-Samplers (VAMS) Prove to be Useful Self-Collection Tools for Assessing Human Exposure to PFAS

LUXEMBOURG--(BUSINESS WIRE)--The American Chemical Society’s Environmental Science and Technology journal recently published a study, “A Self-Collection Blood Test for PFASs: Comparing Volumetric Micro-Samplers with a Traditional Serum Approach” which reports a test developed by Eurofins Environment Testing is a viable self-collection tool for assessing human exposure to PFAS. This method effectively quantifies PFAS in whole blood samples collected by volumetric micro samplers (VAMS).

PFAS, short for per- and polyfluoroalkyl substances, are a class of very stable compounds with unique characteristics making them largely unsusceptible to degradation. Some PFAS accumulate and persist in the environment and in humans. Accumulation of some PFAS in blood has been linked to several negative health outcomes, leading to a need for more epidemiological research.

Historically, serum has been used to conduct biomonitoring of PFAS. Traditional blood collection (serum or plasma) for biomonitoring can be costly and challenging to coordinate and requires the support of a trained phlebotomist. Recent studies have indicated whole blood, collected easily with VAMS, to be a better approach for assessing exposure to a broader suite of PFAS.

Results from the American Chemical Society’s Environmental Science and Technology journal’s study included the sampling and testing of individuals through traditional serum and self-collected VAMS. PFAS levels in serum were highly correlated with measurements in capillary VAMS, indicating that VAMS are useful self-collection tools for assessing human exposure to PFAS.

"This research study is a critical effort, as it provides us with confidence that self-collected blood samples provide just as good – if not, in some cases, better – data on human exposure,” said Christopher P. Higgins, a co-author of the study and University Distinguished Professor of Civil and Environmental Engineering at Colorado School of Mines. “Just as importantly, though, these are much easier to collect than traditional serum samples, and thus this really opens the door for bigger-scale PFAS exposure assessment efforts.”

Self-collected blood samples can help support large scale biomonitoring programs and epidemiologic studies providing a promising solution to several obstacles encountered in biomonitoring studies.

This study was co-authored by Andrew Patterson, Thep Phomsopha, and Eric Redman, all scientists from within the Eurofins Environment Testing network of companies in the USA. Additional co-authors include Courtney Carignan and Rachel Bauer with Michigan State University and Heather Stapleton with Duke University.

Read the published paper in Environmental Science and Technology here.

About Eurofins Environment Testing – USA

The Eurofins environmental laboratories network in the US performs analysis of drinking water, groundwater, seawater, soil, air, and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.

Contacts

Further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

Eurofins Environment Testing – USA

BOURSE:ERF

Release Versions

Contacts

Further information:
Brooke Maharg
Brooke.Maharg@ET.EurofinsUS.com

More News From Eurofins Environment Testing – USA

Eurofins Launches Seventh Buy-Back Programme of Its Own Shares

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (the “Company”) (EUFI.PA) (Paris:ERF) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 4.5% of its share capital. The maximum amount meant for the repurchase of the Company’s shares may not exceed a sum corresponding to an amount equivalent to the value of 4.5% of the shares composing the share capital of the Company as of the Board of Dire...

Eurofins Achieves Organic Growth of 2.6% in Q1 2026, Including Impact of Exceptionally Severe Weather; 2026 and Mid-Term Objectives Reiterated

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: The Eurofins (Paris:ERF) network of companies delivered steady growth despite significant temporary headwinds: Reported revenues in Q1 2026 totalled €1,789m, an increase of 1.3% vs Q1 2025. This was driven by both organic growth13 and acquisitions, with a -4.8% headwind from foreign exchange as the Euro strengthened against most currencies compared to the prior year quarter. Organic revenue growth13 in Q1 2026 was 2.6%, which includes a +0.1% adjust...

Eurofins CDMO Alphora Announces Integration of Advanced Continuous Flow Technology in API Manufacturing

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced, custom-built Continuous Flow (CF) technology to its operations. The company is receiving advisory services and research and development funding support from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) for this project. Developed in-house by Euro...
Back to Newsroom